Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesChange in TaxesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Sunshine Biopharma (SBFM) Change in Inventory (2018 - 2025)

Sunshine Biopharma's Change in Inventory history spans 8 years, with the latest figure at -$772796.0 for Q4 2025.

  • For Q4 2025, Change in Inventory fell 142.82% year-over-year to -$772796.0; the TTM value through Dec 2025 reached $1.6 million, down 72.74%, while the annual FY2025 figure was $1.6 million, 72.74% down from the prior year.
  • Change in Inventory reached -$772796.0 in Q4 2025 per SBFM's latest filing, down from $1.3 million in the prior quarter.
  • In the past five years, Change in Inventory ranged from a high of $2.1 million in Q1 2024 to a low of -$772796.0 in Q4 2025.
  • Average Change in Inventory over 5 years is $502429.3, with a median of $376593.5 recorded in 2023.
  • The largest YoY upside for Change in Inventory was 2456.77% in 2022 against a maximum downside of 702.72% in 2022.
  • A 5-year view of Change in Inventory shows it stood at $34340.0 in 2021, then tumbled by 702.72% to -$206974.0 in 2022, then soared by 652.94% to $1.1 million in 2023, then surged by 57.71% to $1.8 million in 2024, then plummeted by 142.82% to -$772796.0 in 2025.
  • Per Business Quant, the three most recent readings for SBFM's Change in Inventory are -$772796.0 (Q4 2025), $1.3 million (Q3 2025), and $555075.0 (Q2 2025).